CURE vs. RXL

Last updated Apr 2, 2026

Compare and contrast key facts about Direxion Daily Healthcare Bull 3x Shares (CURE) and ProShares Ultra Health Care (RXL).

CURE and RXL are both exchange-traded funds (ETFs), meaning they are traded on stock exchanges and can be bought and sold throughout the day. CURE is a passively managed fund by Direxion that tracks the performance of the Health Care Select Sector Index (300%). It was launched on Jun 15, 2011. RXL is a passively managed fund by ProShares that tracks the performance of the Dow Jones U.S. Health Care Index (200%). It was launched on Jan 30, 2007. Both CURE and RXL are passive ETFs, meaning that they are not actively managed but aim to replicate the performance of the underlying index as closely as possible.

Performance

CURE vs. RXL - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Direxion Daily Healthcare Bull 3x Shares (CURE) and ProShares Ultra Health Care (RXL). The values are adjusted to include any dividend payments, if applicable.

CURE vs. RXL - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
CURE Direxion Daily Healthcare Bull 3x Shares	-15.60%	22.55%	-8.47%	-9.40%	-20.51%	88.30%	5.02%	55.66%	2.82%	69.32%
RXL ProShares Ultra Health Care	-9.67%	19.76%	-2.72%	-3.15%	-15.26%	48.06%	19.24%	40.40%	3.38%	46.92%

Returns By Period

In the year-to-date period, CURE achieves a -15.60% return, which is significantly lower than RXL's -9.67% return. Over the past 10 years, CURE has outperformed RXL with an annualized return of 13.60%, while RXL has yielded a comparatively lower 12.77% annualized return.

CURE

• 1D: 2.50%
• 1M: -19.24%
• YTD: -15.60%
• 6M: 3.42%
• 1Y: -5.59%
• 3Y*: 0.66%
• 5Y*: 3.67%
• 10Y*: 13.60%

RXL

• 1D: 1.75%
• 1M: -12.90%
• YTD: -9.67%
• 6M: 4.12%
• 1Y: 0.69%
• 3Y*: 4.08%
• 5Y*: 4.05%
• 10Y*: 12.77%

*Multi-year figures are annualized to reflect compound growth (CAGR)

CURE vs. RXL - Expense Ratio Comparison

CURE has a 1.08% expense ratio, which is higher than RXL's 0.95% expense ratio.

CURE

Direxion Daily Healthcare Bull 3x Shares

RXL

ProShares Ultra Health Care

Return for Risk

CURE vs. RXL — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

CURE

CURE Risk / Return Rank: 10
CURE Sharpe Ratio Rank: 10
CURE Sortino Ratio Rank: 13
CURE Omega Ratio Rank: 12
CURE Calmar Ratio Rank: 7
CURE Martin Ratio Rank: 7

RXL

RXL Risk / Return Rank: 12
RXL Sharpe Ratio Rank: 12
RXL Sortino Ratio Rank: 14
RXL Omega Ratio Rank: 13
RXL Calmar Ratio Rank: 10
RXL Martin Ratio Rank: 10

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

CURE vs. RXL - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Direxion Daily Healthcare Bull 3x Shares (CURE) and ProShares Ultra Health Care (RXL). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	CURE	RXL	Difference
Sharpe ratio Return per unit of total volatility	-0.11	0.02	-0.13
Sortino ratio Return per unit of downside risk	0.22	0.28	-0.06
Omega ratio Gain probability vs. loss probability	1.03	1.03	-0.01
Calmar ratio Return relative to maximum drawdown	-0.32	-0.10	-0.22
Martin ratio Return relative to average drawdown	-0.59	-0.19	-0.39
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

CURE vs. RXL - Sharpe Ratio Comparison

The current CURE Sharpe Ratio is -0.11, which is lower than the RXL Sharpe Ratio of 0.02. The chart below compares the historical Sharpe Ratios of CURE and RXL, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Sharpe Ratios by Period

	CURE	RXL	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	-0.11	0.02	-0.13
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	0.08	0.14	-0.05
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	0.28	0.39	-0.11
Sharpe Ratio (All Time) Calculated using the full available price history	0.47	0.40	+0.07

Correlation

The correlation between CURE and RXL is 0.97, which is considered to be high. That indicates a strong positive relationship between their price movements. Having highly-correlated positions in a portfolio may signal a lack of diversification, potentially leading to increased risk during market downturns.

Dividends

CURE vs. RXL - Dividend Comparison

CURE's dividend yield for the trailing twelve months is around 1.26%, less than RXL's 1.61% yield.

	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
CURE Direxion Daily Healthcare Bull 3x Shares	1.26%	1.12%	1.17%	2.02%	0.38%	0.02%	0.17%	0.40%	0.70%	0.18%	0.00%	0.00%
RXL ProShares Ultra Health Care	1.61%	1.43%	1.22%	0.18%	0.32%	0.10%	0.15%	0.27%	0.32%	0.11%	0.12%	0.93%

Drawdowns

CURE vs. RXL - Drawdown Comparison

The maximum CURE drawdown since its inception was -69.19%, roughly equal to the maximum RXL drawdown of -67.70%. Use the drawdown chart below to compare losses from any high point for CURE and RXL.

Drawdown Indicators

	CURE	RXL	Difference
Max Drawdown Largest peak-to-trough decline	-69.19%	-67.70%	-1.49%
Max Drawdown (1Y) Largest decline over 1 year	-33.92%	-22.73%	-11.19%
Max Drawdown (5Y) Largest decline over 5 years	-52.23%	-36.08%	-16.15%
Max Drawdown (10Y) Largest decline over 10 years	-69.19%	-51.00%	-18.19%
Current Drawdown Current decline from peak	-33.01%	-17.90%	-15.11%
Average Drawdown Average peak-to-trough decline	-17.95%	-15.82%	-2.13%
Ulcer Index Depth and duration of drawdowns from previous peaks	18.24%	11.68%	+6.56%

Volatility

CURE vs. RXL - Volatility Comparison

Direxion Daily Healthcare Bull 3x Shares (CURE) has a higher volatility of 14.17% compared to ProShares Ultra Health Care (RXL) at 9.47%. This indicates that CURE's price experiences larger fluctuations and is considered to be riskier than RXL based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	CURE	RXL	Difference
Volatility (1M) Calculated over the trailing 1-month period	14.17%	9.47%	+4.70%
Volatility (6M) Calculated over the trailing 6-month period	30.26%	20.60%	+9.66%
Volatility (1Y) Calculated over the trailing 1-year period	52.84%	35.51%	+17.33%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	43.35%	29.34%	+14.01%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	49.47%	33.19%	+16.28%